Serotonin–dopamine reuptake inhibitor
id:
serotonin-dopamine-reuptake-inhibitor-294-12913571
title:
Serotonin–dopamine reuptake inhibitor
text:
A serotonin–dopamine reuptake inhibitor (SDRI) is a type of drug which acts as a reuptake inhibitor of the monoamine neurotransmitters serotonin and dopamine by blocking the actions of the serotonin transporter (SERT) and dopamine transporter (DAT), respectively. This in turn leads to increased extracellular concentrations of serotonin and dopamine, and, therefore, an increase in serotonergic and dopaminergic neurotransmission. A closely related type of drug is a serotonin–dopamine releasing age
brand slug:
wiki
category slug:
encyclopedia
description:
Class of drug
original url:
https://en.wikipedia.org/wiki/Serotonin%E2%80%93dopamine_reuptake_inhibitor
date created:
date modified:
2024-03-30T01:24:03Z
main entity:
{"identifier":"Q17144667","url":"https://www.wikidata.org/entity/Q17144667"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/c/c4/Serotonin-2D-skeletal.svg","width":512,"height":371}
fields total:
13
integrity:
15